Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Janssen
Janssen
Legend Biotech and Janssen establish Belgium cell therapy site
Biopharma Reporter
Mon, 06/28/21 - 10:47 am
Legend Biotech
Janssen
Belgium
cell therapy
Johnson & Johnson single-shot Covid vaccine approved for use in UK
The Guardian, UK
Fri, 05/28/21 - 11:17 am
JNJ
COVID-19
vaccines
UK
Janssen
Straight after its first cancer bispecific OK, J&J highlights two more at ASCO
Pharmaforum
Tue, 05/25/21 - 10:59 am
JNJ
ASCO 2021
talquetamab
teclistamab
Genmab
Janssen
Multiple Myeloma
Guardant’s Partnership with Janssen Bears Fruit
Medical Devices and Diagnostics Industry
Mon, 05/24/21 - 11:25 pm
Guardant Health
Janssen
liquid biopsies
FDA
Guardant 360 CDx
Rybrevant
non-small cell lung cancer
diagnostics
J&J beats Tagrisso and Takeda to the punch in key NSCLC subset, picking up new FDA approval
Endpoints
Sun, 05/23/21 - 03:08 pm
JNJ
non-small cell lung cancer
Janssen
amivantamab
FDA
FDA approves Janssen’s PONVORY for treatment of multiple sclerosis
Pharmaceutical Business Review
Mon, 03/22/21 - 10:35 am
JNJ
Janssen
FDA
Ponvory
relapsing multiple sclerosis
MS
Janssen's Psoriatic Arthritis Drug Proves Long-Term Efficacy in Two-Year Trial
BioSpace
Tue, 03/16/21 - 10:40 pm
JNJ
Janssen
clinical trials
Tremfya
psoriatic arthritis
FDA scientists endorse J&J’s Covid vaccine, as new data shed light on efficacy
Stat
Wed, 02/24/21 - 11:30 am
JNJ
Janssen
FDA
vaccines
COVID-19
As J&J eyes approval for its one-shot COVID-19 vax, it sends off phase 3 data for a swift WHO listing
Fierce Biotech
Sun, 02/21/21 - 11:58 pm
JNJ
WHO
Janssen
COVID-19
vaccines
Janssen's COVID vaccine application submitted to EMA
RAPS.org
Tue, 02/16/21 - 11:38 pm
JNJ
Janssen
EMA
Europe
vaccines
COVID-19
1 Green Flag and 1 Red Flag for Johnson & Johnson's Vaccine Candidate
Motley Fool
Sat, 02/13/21 - 11:07 pm
JNJ
Janssen
vaccines
COVID-19
Janssen Shows 35% Drop in Mortality with Prostate Cancer Drug
BioSpace
Wed, 02/10/21 - 12:01 am
Janssen
JNJ
Erleada
prostate cancer
clinical trials
Janssen flags accelerated approval milestone in Europe for CAR-T therapy
Biopharma Reporter
Mon, 02/1/21 - 11:04 pm
JNJ
Janssen
CAR-T
EMA
Europe
cilta-cel
Verana strikes research collaboration with Janssen on ophthalmology and urology
MedCity News
Wed, 01/27/21 - 08:02 pm
Verana Health
JNJ
Janssen
data analytics
diabetic retinopathy
diabetic macular edema
Chasing BMS, J&J files BCMA CAR-T for multiple myeloma to FDA
Pharmaforum
Tue, 12/22/20 - 10:41 am
JNJ
Janssen
Multiple Myeloma
CAR-T
cilta-cel
FDA
Bristol-Myers Squibb
ide-cel
J&J taps the bispecific experts at Xencor for prostate cancer discovery pact, kicking off with $50M upfront
Endpoints
Mon, 12/7/20 - 10:45 am
JNJ
Xencor
Janssen
bispecific antibodies
prostate cancer
In a first, Janssen submits lung cancer bispecific hopeful amivantamab to the FDA
Fierce Biotech
Thu, 12/3/20 - 10:55 am
Janssen
non-small cell lung cancer
FDA
amivantamab
JNJ
metastatic non-small cell lung cancer
Janssen buys up eye disorder gene therapy asset from Hemera Biosciences
Fierce Biotech
Wed, 12/2/20 - 10:45 am
Janssen
JNJ
Hemera Biosciences
gene therapy
HMR59
geographic atrophy
Pfizer, Moderna apply for EMA authorization; Janssen's candidate begins rolling review
RAPS.org
Tue, 12/1/20 - 11:45 pm
Pfizer
Moderna Therapeutics
Emergency Use Authorization
FDA
vaccines
JNJ
Janssen
Johnson & Johnson assures docs and patients its Janssen pharma unit 'Never Stops'
Fierce Pharma
Wed, 11/25/20 - 10:41 am
JNJ
Janssen
DTC advertising
corporate branding
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »